IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Neuro-Oncology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

9.53

h-Index

2022-2023

 150

Rank

2022-2023

 285

SJR

2022-2023

 4.833

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Neuro-Oncology
Abbreviation Neuro-Oncol.
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q1); Neurology (clinical) (Q1); Oncology (Q1)
h-index 150
Overall Rank/Ranking 285
SCImago Journal Rank (SJR) 4.833
Impact Score 9.53
Publisher Oxford University Press
Country United Kingdom
ISSN 15228517, 15235866
Best Quartile Q1
Coverage History 1999-2022




About Neuro-Oncology


Neuro-Oncology is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Neurology (clinical) (Q1); Oncology (Q1). It is published by Oxford University Press. The overall rank of Neuro-Oncology is 285. According to SCImago Journal Rank (SJR), this journal is ranked 4.833. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 150. The best quartile for this journal is Q1.

The ISSN of Neuro-Oncology journal is 15228517, 15235866. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Neuro-Oncology is cited by a total of 6916 articles during the last 3 years (Preceding 2022).


Neuro-Oncology Impact IF 2022-2023


The Impact IF 2022 of Neuro-Oncology is 9.53, which is computed in 2023 as per its definition. Neuro-Oncology IF is increased by a factor of 2.32 and approximate percentage change is 32.18% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Neuro-Oncology Impact IF 2023 Prediction


Impact IF 2022 of Neuro-Oncology is 9.53. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of Neuro-Oncology. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 9.53
2021 7.21
2020 6.65
2019 6.64
2018 7.31
2017 7.13
2016 6.39
2015 6.25
2014 6.52

Neuro-Oncology h-index


  Table Setting

Neuro-Oncology has an h-index of 150. It means 150 articles of this journal have more than 150 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Neuro-Oncology ISSN


The ISSN of Neuro-Oncology is 15228517, 15235866. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Neuro-Oncology Rank and SCImago Journal Rank (SJR)


The overall rank of Neuro-Oncology is 285. According to SCImago Journal Rank (SJR), this journal is ranked 4.833. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Neuro-Oncology by Year


Year SJR
2023/2024 Coming Soon
2022 4.833
2021 3.097
2020 4.005
2019 4.241
2018 4.098
2017 4.064
2016 3.048
2015 3.246
2014 3.079

Ranking of Neuro-Oncology by Year


Year Ranking
2023/2024 Coming Soon
2022 285
2021 561
2020 389
2019 350
2018 394
2017 392
2016 621
2015 559
2014 635

Neuro-Oncology Publisher


Table Setting

Neuro-Oncology is published by Oxford University Press. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1999-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Neuro-Oncology is Neuro-Oncol.. This abbreviation ('Neuro-Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Neuro-Oncology


If your research field is/are related to Cancer Research (Q1); Neurology (clinical) (Q1); Oncology (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Neuro-Oncology?

Neuro-Oncology latest impact IF is 9.53. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 9.53 (2022) and 6.25 (2015), respectively, in the last 9 years. Moreover, its average IS is 7.07 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Neuro-Oncology?

The Neuro-Oncology has an SJR (SCImago Journal Rank) of 4.833, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 4.833 in 2022 and the lowest being 3.048 in 2016. Furthermore, the average SJR of the Neuro-Oncology over the previous 9-year period stands at 7.07.


What's the latest h-index of the Neuro-Oncology?

The latest h-index of the Neuro-Oncology is 150.


Who's the publisher of the Neuro-Oncology?

The Neuro-Oncology is published by the Oxford University Press, with its country of publication being the United Kingdom.


What's the current ranking of the Neuro-Oncology?

The Neuro-Oncology is currently ranked 285 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 285 in 2022 and its lowest position of 635 in 2014.


What's the abbreviation or short name for the Neuro-Oncology?

The standard ISO4 abbreviation for the Neuro-Oncology is Neuro-Oncol..


Is the "Neuro-Oncology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Neuro-Oncology is classified as a journal that the Oxford University Press publishes.


What's the scope or major areas of the Neuro-Oncology?

The Neuro-Oncology encompasses the following areas:

  • Cancer Research
  • Neurology (clinical)
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Neuro-Oncology?

The Neuro-Oncology is assigned the following International Standard Serial Numbers (ISSN): 15228517, 15235866.


What's the best quartile of the Neuro-Oncology?

The best quartile for the Neuro-Oncology is Q1 (2022).


What's the coverage history of the Neuro-Oncology?

The Neuro-Oncology coverage history can be summarized as follows: 1999-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Proceedings of the ASME Turbo Expo conference and proceedings 17577 54 0.00
Analysis in Theory and Applications journal 19346 Springer Netherlands 11 0.00
Journal of Classical Sociology journal 13766 SAGE Publications Ltd 27 0.83
Natural Solutions trade journal 28581 Innovision Health Media 1 0.00
Museum Management and Curatorship journal 8168 Routledge 37 2.65
Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria journal 25905 National Association of Resident Doctors of Nigeria 25 0.00
Consulting engineer Barrington journal 24079 Cahners Pub. Co. 0 0.00
Expert Review of Clinical Pharmacology journal 5241 Taylor and Francis Ltd. 53 4.10
Clinical Interventions in Aging journal 4777 Dove Medical Press Ltd. 96 3.57
English Literary Renaissance journal 23442 University of Chicago Press 20 0.25

Check complete list




Year wise Impact Score (IS) of Neuro-Oncology

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 9.53
2021 7.21
2020 6.65
2019 6.64
2018 7.31
2017 7.13
2016 6.39
2015 6.25
2014 6.52



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All